#1 Clinical Trials Search in Europe

Ranitidine Hydrochloride

Ranitidine Hydrochloride, commonly known as Zantac, has been the subject of numerous clinical trials to evaluate its effectiveness in treating various conditions. This article explores the use of Ranitidine Hydrochloride in clinical studies, focusing on its applications, comparisons with other medications, and potential benefits for patients with different health concerns.

Table of Contents

What is Ranitidine Hydrochloride?

Ranitidine Hydrochloride, commonly known by its brand name Zantac, is a medication that belongs to a class of drugs called histamine-2 (H2) receptor antagonists[1]. These drugs work by reducing the amount of acid produced in the stomach. Ranitidine is available in various forms, including tablets, oral solutions, and intravenous (IV) formulations[3].

Medical Uses

Ranitidine Hydrochloride is used to treat a variety of conditions related to excess stomach acid. These include:

  • Dyspepsia: This is a general term for indigestion, which can include symptoms like upper abdominal pain, bloating, and nausea[3].
  • Gastric Ulcers: Ranitidine can be used to heal ulcers in the stomach, particularly those associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs)[6].
  • Stress Ulcer Prophylaxis: In critically ill patients, ranitidine may be used to prevent stress-related ulcers from forming in the stomach[10].
  • Gastroesophageal Reflux Disease (GERD): While not explicitly mentioned in the trials, ranitidine is commonly used to treat GERD symptoms.

How is Ranitidine Administered?

Ranitidine can be administered in several ways, depending on the condition being treated and the patient’s needs:

  • Oral tablets: These are available in various strengths, including 150 mg and 300 mg[4].
  • Intravenous (IV) injection: In hospital settings, ranitidine may be given as an IV infusion, typically in doses of 50 mg[3].
  • Oral Disintegrating Tablets (ODT): These are tablets that dissolve in the mouth without needing water[1].

The dosage and frequency of administration can vary depending on the condition being treated. For example, in some studies, ranitidine was given as 150 mg twice daily[6].

Effectiveness

Ranitidine has been shown to be effective in various clinical scenarios:

  • Healing of gastric ulcers: Studies have compared ranitidine to other medications like esomeprazole for healing NSAID-associated gastric ulcers[6].
  • Relief of dyspeptic pain: Ranitidine has been studied for its ability to reduce pain associated with dyspepsia in emergency department settings[3].
  • Increasing gastric pH: In critically ill patients, ranitidine has been shown to increase gastric pH, which can help prevent stress ulcers[10].

Side Effects and Safety

Ranitidine is generally considered safe and well-tolerated. However, like all medications, it can have side effects. Common side effects may include headache, dizziness, and gastrointestinal disturbances. In clinical trials, researchers often monitor for adverse events to ensure the safety of the medication[6].

It’s important to note that in recent years, there have been concerns about potential contamination of some ranitidine products with a substance called N-nitrosodimethylamine (NDMA). This led to recalls in some countries. Patients should always consult with their healthcare provider about the most current safety information.

Comparisons with Other Medications

Several studies have compared ranitidine to other medications used for similar purposes:

  • Esomeprazole: This is a proton pump inhibitor (PPI) that has been compared to ranitidine for healing gastric ulcers and treating dyspepsia[6][3].
  • Pantoprazole: Another PPI that has been compared to ranitidine for treating dyspepsia in emergency department settings[9].

These comparisons help healthcare providers determine the most appropriate treatment for each patient’s specific condition.

Ongoing Research

Research on ranitidine continues to explore its potential benefits beyond its traditional uses:

  • HIV research: Some studies have investigated whether ranitidine can enhance the effectiveness of other medications in HIV treatment[5].
  • Cancer research: Preliminary studies have looked at whether ranitidine might have effects on the immune system that could be beneficial in cancer treatment[7]. However, it’s important to note that this is still in the research phase and ranitidine is not approved as a cancer treatment.

These ongoing studies highlight the continued interest in understanding the full potential of ranitidine in various medical contexts.

Aspect Details
Primary Uses in Trials Treatment of dyspepsia, healing of NSAID-associated gastric ulcers, potential enhancement of anti-tumor immunity, effects on immunologic indicators in HIV patients
Comparison Medications Esomeprazole, pantoprazole, placebo
Administration Methods Oral tablets, intravenous infusions, oral disintegrating tablets (ODT)
Key Outcome Measures Healing rate of gastric ulcers, reduction in dyspeptic pain, changes in immunologic indicators, bioavailability
Unique Applications Potential enhancement of anti-tumor immunity, effects on immune cell function in healthy humans
Safety Considerations Generally well-tolerated, with safety and tolerability assessed in trials

FAQ

  • What is Ranitidine Hydrochloride used for in clinical trials? Ranitidine Hydrochloride is used in clinical trials for various purposes, including treating dyspepsia (indigestion), healing NSAID-associated gastric ulcers, and potentially enhancing anti-tumor immunity. It's also studied for its effects on immunologic indicators in HIV-infected patients.
  • How does Ranitidine Hydrochloride compare to other medications in trials? Clinical trials often compare Ranitidine Hydrochloride to other medications like esomeprazole, pantoprazole, and placebo. These comparisons help determine the relative effectiveness of Ranitidine in treating conditions such as dyspepsia and gastric ulcers.
  • What are some of the primary outcomes measured in Ranitidine Hydrochloride trials? Primary outcomes in Ranitidine Hydrochloride trials often include the healing rate of gastric ulcers, reduction in dyspeptic pain, changes in immunologic indicators, and bioavailability measurements. Researchers also assess safety and tolerability of the drug.
  • Are there any unique applications of Ranitidine Hydrochloride being studied? Yes, some unique applications being studied include its potential to enhance anti-tumor immunity and its effects on immune cell function in healthy humans. There's also research on its impact on immunologic indicators in HIV-infected patients.
  • How is Ranitidine Hydrochloride administered in clinical trials? In clinical trials, Ranitidine Hydrochloride is administered in various forms, including oral tablets, intravenous infusions, and oral disintegrating tablets (ODT). The dosage and frequency vary depending on the specific study and condition being treated.

Ongoing Clinical Trials on Ranitidine Hydrochloride

  • Study of SKB264 and Pembrolizumab for Treating Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Romania Spain

  • Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

Glossary

  • Bioavailability: The proportion of a drug or other substance which enters the circulation when introduced into the body and so is able to have an active effect.
  • Dyspepsia: Indigestion or upset stomach, characterized by pain or discomfort in the upper abdomen.
  • Gastric Ulcer: An open sore that develops on the lining of the stomach.
  • NSAID: Non-Steroidal Anti-Inflammatory Drug, a type of medication used to reduce pain, fever, and inflammation.
  • Proton Pump Inhibitor (PPI): A type of medication that reduces stomach acid production, such as esomeprazole.
  • H2 Receptor Antagonist: A type of medication that blocks histamine receptors in the stomach to reduce acid production, such as Ranitidine.
  • Oral Disintegrating Tablet (ODT): A tablet designed to dissolve quickly in the mouth without the need for water.
  • Visual Analogue Scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured, often used for pain assessment.
  • Immunologic Indicators: Markers or measurements that reflect the status or function of the immune system.
  • Myeloid Derived Suppressor Cells (MDSC): A type of immune cell that can suppress the immune response, often studied in cancer research.

References

  1. https://clinicaltrials.gov/study/NCT02195804
  2. https://clinicaltrials.gov/study/NCT00002106
  3. https://clinicaltrials.gov/study/NCT02197143
  4. https://clinicaltrials.gov/study/NCT01131702
  5. https://clinicaltrials.gov/study/NCT00000964
  6. https://clinicaltrials.gov/study/NCT00401752
  7. https://clinicaltrials.gov/study/NCT03145012
  8. https://clinicaltrials.gov/study/NCT00633672
  9. https://clinicaltrials.gov/study/NCT01737840
  10. https://clinicaltrials.gov/study/NCT00590928